Yuan, Qianying <br/><br/>
A new protoapigenone analog RY10-4 induces apoptosis and suppresses invasion through the PI3K/Akt pathway in human breast cancer.  [electronic resource] 

 -  Cancer letters  Nov 2012 
 - 210-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2012.05.025  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Neoplasm Invasiveness<br/>Phosphatidylinositol 3-Kinase--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Pyrones--pharmacology<br/>S Phase Cell Cycle Checkpoints--drug effects<br/>Signal Transduction--drug effects<br/>Time Factors<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays